Rhythm Pharmaceuticals announces proposed public offering
Rhythm Pharma announced a proposed public offering of up to $150 million of shares of its common stock. Rhythm intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of common stock at the public offering price, less the underwriting discount. October 15, 2019